Human Genome Epidemiology Literature Finder
|
Records 1 - 8 (of 8 Records) |
| Query Trace: Coronary artery disease and meta-analysis and PCSK9[original query] |
|---|
Newly identified loci that influence lipid concentrations and risk of coronary artery disease.
Nature genetics 2008 Feb 40 (2): 161-9. Willer Cristen J, Sanna Serena, Jackson Anne U, Scuteri Angelo, Bonnycastle Lori L, Clarke Robert, Heath Simon C, Timpson Nicholas J, Najjar Samer S, Stringham Heather M, Strait James, Duren William L, Maschio Andrea, Busonero Fabio, Mulas Antonella, Albai Giuseppe, Swift Amy J, Morken Mario A, Narisu Narisu, Bennett Derrick, Parish Sarah, Shen Haiqing, Galan Pilar, Meneton Pierre, Hercberg Serge, Zelenika Diana, Chen Wei-Min, Li Yun, Scott Laura J, Scheet Paul A, Sundvall Jouko, Watanabe Richard M, Nagaraja Ramaiah, Ebrahim Shah, Lawlor Debbie A, Ben-Shlomo Yoav, Davey-Smith George, Shuldiner Alan R, Collins Rory, Bergman Richard N, Uda Manuela, Tuomilehto Jaakko, Cao Antonio, Collins Francis S, Lakatta Edward, Lathrop G Mark, Boehnke Michael, Schlessinger David, Mohlke Karen L, Abecasis Gonçalo |
| The associations between proprotein convertase subtilisin/kexin type 9 E670G polymorphism and the risk of coronary artery disease and serum lipid levels: a meta-analysis. Lipids in health and disease 2015 14 (1): 149. Cai Gaojun, Zhang Bifeng, Shi Ganwei, Weng Weijin, Ma Chunyan, Song Yanbin, Zhang |
| Coding-sequence variants are associated with blood lipid levels in 14,473 Chinese. Human molecular genetics 2016 Aug . Lu Xiangfeng, Li Jun, Li Huaixing, Chen Yang, Wang Laiyuan, He Meian, Wang Yiqin, Sun Liang, Hu Yao, Huang Jianfeng, Wang Feijie, Liu Xuezhen, Chen Shufeng, Yu Kuai, Yang Xueli, Mo Zengnan, Lin Xu, Wu Tangchun, Gu Dongfe |
| Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis. JAMA 2016 Oct 316 (13): 1383-1391. Lotta Luca A, Sharp Stephen J, Burgess Stephen, Perry John R B, Stewart Isobel D, Willems Sara M, Luan Jian'an, Ardanaz Eva, Arriola Larraitz, Balkau Beverley, Boeing Heiner, Deloukas Panos, Forouhi Nita G, Franks Paul W, Grioni Sara, Kaaks Rudolf, Key Timothy J, Navarro Carmen, Nilsson Peter M, Overvad Kim, Palli Domenico, Panico Salvatore, Quirós Jose-Ramón, Riboli Elio, Rolandsson Olov, Sacerdote Carlotta, Salamanca-Fernandez Elena, Slimani Nadia, Spijkerman Annemieke M W, Tjonneland Anne, Tumino Rosario, van der A Daphne L, van der Schouw Yvonne T, McCarthy Mark I, Barroso Inês, O'Rahilly Stephen, Savage David B, Sattar Naveed, Langenberg Claudia, Scott Robert A, Wareham Nicholas |
| PCSK9 loss of function is protective against extra-coronary atherosclerotic cardiovascular disease in a large multi-ethnic cohort. PloS one 2020 11 15 (11): e0239752. Small Aeron M, Huffman Jennifer E, Klarin Derek, Lynch Julie A, Assimes Themistocles, DuVall Scott, Sun Yan V, Shere Labiba, Natarajan Pradeep, Gaziano Michael, Rader Daniel J, Wilson Peter W F, Tsao Philip S, Chang Kyong-Mi, Cho Kelly, O'Donnell Christopher J, Casas Juan P, Damrauer Scott M, |
| PCSK9 Gene E670G Polymorphism and Coronary Artery Disease: An Updated Meta-Analysis of 5,484 Subjects. Frontiers in cardiovascular medicine 2020 11 7 582865. Li Yan-Yan, Wang Hui, Yang Xin-Xing, Geng Hong-Yu, Gong Ge, Lu Xin-Zhe |
| Meta-GWAS of PCSK9 levels detects two novel loci at APOB and TM6SF2.
Human molecular genetics 2021 10 31 (6): 999-1011. Pott Janne, Gådin Jesper R, Theusch Elizabeth, Kleber Marcus E, Delgado Graciela E, Kirsten Holger, Hauck Stefanie M, Burkhardt Ralph, Scharnagl Hubert, Krauss Ronald M, Loeffler Markus, März Winfried, Thiery Joachim, Silveira Angela, Van't Hooft Ferdinand M, Scholz Mark |
| PCSK9 inhibitors and osteoporosis: mendelian randomization and meta-analysis. BMC musculoskeletal disorders 2024 7 25 (1): 548. Ding-Qiang Chen, Wen-Bin Xu, Ke-Yi Xiao, Zhi-Qiang Que, Jin-Yi Feng, Nai-Kun Sun, Di-Xin Cai, Gang R |
- Page last reviewed:Feb 1, 2024
- Content source: